4,0
17 dec 2024
Huidige werknemer
Los Angeles, CA
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Great benefits, WFH, unlimited PTO
Minpunten
Company has gone from customer focused to supporting big pharma as the main objective it seems. Sort of lost it's way a bit since going public but still doing good things overall for consumers.